Literature DB >> 33659936

Recent advances in managing primary hypertension.

Ioannis Leontsinis1, Manos Mantzouranis1, Panagiotis Tsioufis1, Ioannis Andrikou1, Costas Tsioufis1.   

Abstract

Hypertension remains a leading risk factor for cardiovascular mortality and morbidity globally despite the availability of effective and well-tolerated antihypertensive medications. Accumulating evidence suggests a more aggressive blood pressure regulation aimed at lower targets, particularly for selected patient groups. Our concepts of the optimal method for blood pressure measurement have radically changed, maintaining appropriate standard office measurements for initial assessment but relying on out-of-office measurement to better guide our decisions. Thorough risk stratification provides guidance in decision making; however, an individualized approach is highly recommended to prevent overtreatment. Undertreatment, on the other hand, remains a major concern and is mainly attributed to poor adherence and resistant or difficult-to-control forms of the disease. This review aims to present modern perspectives, novel treatment options, including innovative technological applications and developing interventional and pharmaceutical therapies, and the major concerns emerging from several years of research and epidemiological observations related to hypertension management. Copyright:
© 2020 Tsioufis C et al.

Entities:  

Keywords:  difficult to treat hypertension; hypertension; hypertension management; neuromodulation; novel antihypertensives; resistant hypertension

Year:  2020        PMID: 33659936      PMCID: PMC7894269          DOI: 10.12703/b/9-4

Source DB:  PubMed          Journal:  Fac Rev        ISSN: 2732-432X


  1 in total

Review 1.  Highlights of Cardiovascular Disease Studies Presented at the 2021 American Heart Association Scientific Sessions.

Authors:  Michelle T Lee; Jerin George; Hunaina Shahab; Melody Hermel; Jamal S Rana; Salim S Virani
Journal:  Curr Atheroscler Rep       Date:  2022-01-24       Impact factor: 5.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.